PRODUCT LITERATURE
Bioavailability of fondaparinux to critically ill patients
Venous thromboembolism is a common problem in the intensive care unit (ICU). To decrease its incidence, prophylactic pharmacologic
interventions are part of the ICU routine. However, common ICU conditions may impair the bioavailability of subcutaneously administered agents.
The present study evaluates the bioavailability of prophylactic subcutaneous fondaparinux to critically ill patients
No other version available